What is Broncus Medical?
Broncus Medical, established in 2012, is dedicated to pioneering diagnostic and therapeutic technologies for a spectrum of lung diseases. The company's core innovation lies in its technology platforms targeting the diagnosis of lung cancer and the treatment of emphysema. Its comprehensive portfolio includes advanced systems such as the Archimedes® System, Archimedes® Lite Virtual Bronchoscopic Navigation (VBN) System, Archimedes® Planner, and the FleXNeedle® device, positioning Broncus Medical as a significant player in the respiratory medical technology sector.
How much funding has Broncus Medical raised?
Broncus Medical has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Broncus Medical?
With its substantial capital base and a clear focus on late-stage development, Broncus Medical is poised for significant growth and market penetration. The company's strategic objective is likely to further refine its diagnostic and therapeutic offerings, potentially expanding clinical trials and seeking regulatory approvals to bring its innovative solutions to a wider patient population. Continued investment in these areas will be crucial for solidifying its market position and addressing unmet needs in lung disease management.
See full Broncus Medical company page
